Literature DB >> 30878092

Characterization of a novel cathepsin L-like protease from Taenia solium metacestodes for the immunodiagnosis of porcine cysticercosis.

Nancy León-Janampa1, Ruddy Liendo2, Robert H Gilman3, Carlos Padilla4, Hector H García5, Armando Gonzales6, Patricia Sheen7, Mónica J Pajuelo8, Mirko Zimic9.   

Abstract

Porcine cysticercosis is an endemic parasitic disease caused by infection with Taenia solium that is found predominantly in developing countries. In order to aid in the development of simple diagnostic approaches, identification and characterization of potential new antigens for immunodiagnostic purposes is desired. The cysteine protease family has previously been found to have important immunodiagnostic properties. These proteases are expressed as zymogens which contain a signal peptide, pro-peptide, and an active domain. Subsequent catalytic cleavage of the pro-peptide converts these zymogens into enzymes. With the use of bioinformatic tools we identified an active domain of a novel cathepsin L-like cysteine protease (TsolCL) in the T. solium genome. The TsolCL gene includes 705 nucleotides (nt) within a single intron and a 633 nt exonic sequence encoding an active protein of 211 amino acids. Sequence alignment and phylogenetic analysis suggest that the TsolCL gene is closely related to genes found in Echinoccocus granulosus and E. multiloculars. In addition, TsolCL was found to have a 61.9%-99.0% similarity to other cathepsin L proteins found in other helminths and mammals. We cloned, expressed, purified, and characterized the recombinant active TsolCL (27 kDa) using the baculovirus-insect cell expression system. TsolCL showed cysteine protease enzymatic activity with the capacity to hydrolyze the Z-Phe-Arg-AMC substrate as well as bovine serum albumin. However, TsolCL was not able to hydrolyze human immunoglobulin. In addition, TsolCL has cathepsin L conserved amino acid residues in the catalytic site (Gln8, Cys14, His159, Asn179 and Trp181) and the motif GCNGG. Using ELISA, TsolCL was able to distinguish circulating IgG antibodies between healthy animals and naturally infected pigs with cysticercosis, showing a moderate sensitivity of 83.33% (40/48; 95% CI: [69.8%-92.5 %]), and a specificity of 83.78% (31/37; 95% CI: [67.9%-93.8%]). In conclusion, a novel cathepsin L-like cysteine protease from a T. solium metacestode was expressed successfully in Baculovirus system and was evaluated as a candidate antigen to diagnose porcine cysticercosis using the ELISA immunoassay.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Baculovirus expression vector system; Cathepsin L; Cysticercosis; Immunodiagnosis; Taenia solium

Mesh:

Substances:

Year:  2019        PMID: 30878092      PMCID: PMC7010362          DOI: 10.1016/j.vetpar.2019.01.004

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  34 in total

Review 1.  Eradication of Taenia solium cysticercosis: a role for vaccination of pigs.

Authors:  Marshall W Lightowlers
Journal:  Int J Parasitol       Date:  2010-05-12       Impact factor: 3.981

2.  Identification and characterization of a cathepsin L-like cysteine protease from Taenia solium metacestode.

Authors:  Ai Hua Li; Sung-Ung Moon; Yun-Kyu Park; Byoung-Kuk Na; Myung-Gi Hwang; Chang-Mi Oh; Shin-Hyeong Cho; Yoon Kong; Tong-Soo Kim; Pyung-Rim Chung
Journal:  Vet Parasitol       Date:  2006-07-25       Impact factor: 2.738

3.  Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru.

Authors:  S M Montano; M V Villaran; L Ylquimiche; J J Figueroa; S Rodriguez; C T Bautista; A E Gonzalez; V C W Tsang; R H Gilman; H H Garcia
Journal:  Neurology       Date:  2005-07-26       Impact factor: 9.910

4.  Cloning and characterization of a cathepsin L-like cysteine protease from Taenia pisiformis.

Authors:  Qiuxia Wang; Shaohua Zhang; Xuenong Luo; Junling Hou; Xueliang Zhu; Xuepeng Cai
Journal:  Vet Parasitol       Date:  2013-01-09       Impact factor: 2.738

5.  Evaluation of activity of triclabendazole against Taenia solium metacestode in naturally infected pigs.

Authors:  Ana Vargas-Calla; Luis A Gomez-Puerta; Juan Calcina; Omar Gonzales-Viera; Cesar Gavidia; Maria T Lopez-Urbina; Hector H Garcia; Armando E Gonzalez
Journal:  Asian Pac J Trop Med       Date:  2015-12-19       Impact factor: 1.226

6.  Swine cysticercosis hotspots surrounding Taenia solium tapeworm carriers.

Authors:  Andres G Lescano; Hector H Garcia; Robert H Gilman; M Claudia Guezala; Victor C W Tsang; Cesar M Gavidia; Silvia Rodriguez; Lawrence H Moulton; Justin A Green; Armando E Gonzalez
Journal:  Am J Trop Med Hyg       Date:  2007-02       Impact factor: 2.345

7.  The marketing of cysticercotic pigs in the Sierra of Peru. The Cysticercosis Working Group in Peru.

Authors: 
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

8.  Hepatic changes in congenital Schistosoma japonicum infections in pigs.

Authors:  T Iburg; M V Johansen; P S Leifsson; A L Willingham; R Lindberg
Journal:  J Comp Pathol       Date:  2007-04-24       Impact factor: 1.311

Review 9.  Production of recombinant proteins by microbes and higher organisms.

Authors:  Arnold L Demain; Preeti Vaishnav
Journal:  Biotechnol Adv       Date:  2009-01-31       Impact factor: 14.227

Review 10.  Cysteine proteases during larval migration and development of helminths in their final host.

Authors:  Alexandra Grote; Conor R Caffrey; Karina M Rebello; David Smith; John P Dalton; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2018-08-23
View more
  2 in total

1.  Molecular characterization and determination of the biochemical properties of cathepsin L of Trichinella spiralis.

Authors:  Ruo Dan Liu; Xiang Yu Meng; Chen Le Li; Shao Rong Long; Jing Cui; Zhong Quan Wang
Journal:  Vet Res       Date:  2022-06-23       Impact factor: 3.829

Review 2.  Taenia solium Cysticercosis and Its Impact in Neurological Disease.

Authors:  Hector H Garcia; Armando E Gonzalez; Robert H Gilman
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.